Literature DB >> 25469977

Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals.

Takeshi Kimura1, Gautam A Deshpande, Kevin Y Urayama, Katsunori Masuda, Tsuguya Fukui, Yutaka Matsuyama.   

Abstract

BACKGROUND AND AIMS: Interventions for lifestyle diseases including non-alcoholic fatty liver disease (NAFLD) have focused on overweight and obese populations. The impact of adult weight gain on NAFLD development among normal weight individuals remains unclear.
METHODS: In this cross-sectional study, we collected data from participants presenting to a health check-up program. Ultrasound-diagnosed NAFLD prevalence was examined over 1-kg increments of weight change since age 20. Relative risks were calculated in men and women stratified by current weight (normal, overweight, and obese). Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) adjusting for potential confounders.
RESULTS: Among 21 496 participants, 3498 cases of NAFLD (16.3%) were observed. Prevalence of NAFLD increased with weight gain since age 20; among the 10.1-11.0 kg weight gain group, 41.6% of men and 24.8% of women had NAFLD. Multivariate analysis by quartiles showed that weight change was significantly associated with NAFLD risk in men and women. Risk of NAFLD associated with weight change (10-kg increments) was significantly higher in normal weight individuals (men: OR 7.53, 95% CI: 4.99-11.36, women: OR 12.20, 95% CI: 7.45-19.98) than overweight (men: OR 1.61, 95% CI: 0.91-2.85, women: OR 2.90, 95% CI: 0.99-8.54) and obese (men: OR 4.0, 95% CI: 2.97-5.39, women: OR 2.68, 95% CI: 2.00-3.60).
CONCLUSIONS: NAFLD is robustly associated with weight change since age 20. This effect appears particularly strong in individuals at normal weight, suggesting an important role for early and longitudinal weight monitoring, even among healthy individuals at normal weight.
© 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  body weight gain; non-alcoholic steatohepatitis; prevention and control

Mesh:

Year:  2015        PMID: 25469977     DOI: 10.1111/jgh.12861

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

1.  Physiological Mechanisms of Weight Gain-Induced Steatosis in People With Obesity.

Authors:  Elisa Fabbrini; Courtney Tiemann Luecking; Latisha Love-Gregory; Adewole L Okunade; Mihoko Yoshino; Gemma Fraterrigo; Bruce W Patterson; Samuel Klein
Journal:  Gastroenterology       Date:  2015-09-12       Impact factor: 22.682

2.  The Impact of PNPLA3 rs738409 Genetic Polymorphism and Weight Gain ≥10 kg after Age 20 on Non-Alcoholic Fatty Liver Disease in Non-Obese Japanese Individuals.

Authors:  Kenichi Nishioji; Naomi Mochizuki; Masao Kobayashi; Mai Kamaguchi; Yoshio Sumida; Takeshi Nishimura; Kanji Yamaguchi; Hiroshi Kadotani; Yoshito Itoh
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

3.  Association of alcohol consumption with prevalence of fatty liver after adjustment for dietary patterns: Cross-sectional analysis of Japanese middle-aged adults.

Authors:  Ryoko Tajima; Fumiaki Imamura; Takeshi Kimura; Satomi Kobayashi; Katsunori Masuda; Kaoruko Iida
Journal:  Clin Nutr       Date:  2019-07-26       Impact factor: 7.324

4.  Risk Factors Associated With Chronic Liver Enzyme Elevation in Persons With HIV Without Hepatitis B or C Coinfection in the Combination Antiretroviral Therapy Era.

Authors:  Shannon Wood; Seung Hyun Won; Hsing-Chuan Hsieh; Tahaniyat Lalani; Karl Kronmann; Ryan C Maves; Gregory Utz; Christina Schofield; Rhonda E Colombo; Jason F Okulicz; Jason Blaylock; Brian K Agan; Anuradha Ganesan
Journal:  Open Forum Infect Dis       Date:  2021-02-24       Impact factor: 3.835

5.  Body mass index trajectories in young adulthood predict non-alcoholic fatty liver disease in middle age: The CARDIA cohort study.

Authors:  Lisa B VanWagner; Sadiya S Khan; Hongyan Ning; Juned Siddique; Cora E Lewis; John J Carr; Miriam B Vos; Elizabeth Speliotes; Norah A Terrault; Mary E Rinella; Donald M Lloyd-Jones; Norrina B Allen
Journal:  Liver Int       Date:  2017-10-13       Impact factor: 8.754

6.  Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005-2014.

Authors:  Jennifer K Frediani; Eric A Naioti; Miriam B Vos; Janet Figueroa; Carmen J Marsit; Jean A Welsh
Journal:  Environ Health       Date:  2018-01-15       Impact factor: 5.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.